Mangoceuticals (MGRX) Inventory (2023 - 2024)
Mangoceuticals recorded quarterly Inventory of -$18501.0 in Q4 2024, down 240.02% quarter-over-quarter from $13213.0 in Q3 2024, and down 200.0% year-over-year from $18501.0 in Q1 2024.
Mangoceuticals' Inventory history runs 2 years deep, the most recent figure standing at -$18501.0 for Q4 2024.
- In Q4 2024, Inventory fell 200.0% year-over-year to -$18501.0; the TTM figure through Dec 2024 stood at -$18501.0 (down 200.0% YoY), while the FY2024 annual figure was -$18501.0, down 200.0% from the prior year.
- Inventory came in at -$18501.0 for Q4 2024 at Mangoceuticals, down from $13213.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $23494.0 in Q2 2023 to a low of -$18501.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 560.17 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 14.17 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 53.49 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 99.20 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -18,501.00 |
| Sep 30, 2024 | 13,213.00 |
| Jun 30, 2024 | 14,019.00 |
| Mar 31, 2024 | 14,452.00 |
| Dec 31, 2023 | 18,501.00 |
| Sep 30, 2023 | 21,581.00 |
| Jun 30, 2023 | 23,494.00 |